Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

NUMD Nu-Med Plus, Inc.

Discussion in 'Penny Stocks' started by Giants1967, Jan 7, 2020.

  1. Giants1967

    Giants1967 Member

    Joined:
    Dec 2, 2019
    Messages:
    573
    Likes Received:
    4
  2. Giants1967

    Giants1967 Member

    Joined:
    Dec 2, 2019
    Messages:
    573
    Likes Received:
    4
    Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19


    Nu-Med Plus, Inc
    . (NUMD),
    a medical device company which investigates and develops applications and devices for nitric oxide in the medical field, today announced that the Company is closely monitoring two new clinical trials that are testing Nitric Oxide Gas Inhalation Therapy for the treatment of mild/moderate COVID-19. The two new human Phase 2 clinical trials were announced at the beginning of March 2020 and are a collaboration of Xijing Hospital in China and Massachusetts General Hospital.

    In the past, inhaled nitric oxide (iNO) has been used as a supportive measure in treating patients infected with coronavirus (SARS-CoV) and exhibiting associated pulmonary complications. Data on SARS-CoV suggest that iNO could have a similar effect on COVID-19 due to the genomic similarities between the two coronaviruses.

    https://clinicaltrials.gov/ct2/show/NCT04305457?term=Nitric+Oxide&cond=COVID-19&draw=2&rank=1

    https://clinicaltrials.gov/ct2/show/NCT04290871?id=NCT04290871&draw=2&rank=1&load=cart

    NU-MED at present is in communications with the FDA about guidance relating to getting several of its products into the market more quickly, as well as in discussions with Veterans Administration about research opportunities relating to the INO technology and COVID-19. NU-MED is also in discussions with the representatives of the city of Guanghzou, China regarding a project relating to INO and the Coronavirus.

    in vitro it has demonstrated an inhibitory effect on the replication cycle of SARS-CoV providing a strong basis for the clinical trials.   We are watching the clinical trials closely for positive results in treatment of COVID-19. Our patent pending nitic oxide disposable delivery device may possibly make a difference in helping to combat this disease and others in the future.”" data-reactid="18">Mr. Jeff Robins, CEO of Nu-Med Plus, commented, “Scientists continue to research and recognize the impressive healing power of inhaled nitric oxide to help alleviate a diverse array of global health conditions. While nitric oxide has not been specifically studied or used to treat COVID-19, in vitro it has demonstrated an inhibitory effect on the replication cycle of SARS-CoV providing a strong basis for the clinical trials. We are watching the clinical trials closely for positive results in treatment of COVID-19. Our patent pending nitic oxide disposable delivery device may possibly make a difference in helping to combat this disease and others in the future.”
     
    demat166 likes this.
  3. Giants1967

    Giants1967 Member

    Joined:
    Dec 2, 2019
    Messages:
    573
    Likes Received:
    4

Share This Page